###begin article-title 0
Spinal Cord Injury Reveals Multilineage Differentiation of Ependymal Cells
###end article-title 0
###begin p 1
Spinal cord injury often results in permanent functional impairment. Neural stem cells present in the adult spinal cord can be expanded in vitro and improve recovery when transplanted to the injured spinal cord, demonstrating the presence of cells that can promote regeneration but that normally fail to do so efficiently. Using genetic fate mapping, we show that close to all in vitro neural stem cell potential in the adult spinal cord resides within the population of ependymal cells lining the central canal. These cells are recruited by spinal cord injury and produce not only scar-forming glial cells, but also, to a lesser degree, oligodendrocytes. Modulating the fate of ependymal progeny after spinal cord injury may offer an alternative to cell transplantation for cell replacement therapies in spinal cord injury.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 121 129 <span type="species:ncbi:9606">patients</span>
Spinal cord injuries occur in more than 30.000 individuals each year worldwide and result in significant morbidity, with patients requiring long physical and medical care. The recent identification of resident stem cells in the adult spinal cord has opened up for the possibility of pharmacological manipulation of these cells to produce cell types promoting recovery after injury. We have employed genetic tools to specifically address the identity and reaction to injury of a spinal cord subpopulation of cells known as ependymal cell. Genetic labeling of this putative stem cell population allows for the evaluation of stem cell activity in vitro and in vivo. We found that ependymal cells lining the central canal act as neural stem cells in vitro and contribute extensively to the glial scar in vivo. Interestingly, injury induces proliferation of ependymal cells and migration of ependyma-derived progeny towards the site of injury. Moreover, ependymal cell progeny differentiate and give rise to astrocytes as well as myelinating oligodendrocytes. In summary, our results point to ependymal cells as an attractive candidate population for non-invasive manipulation after injury.
###end p 4
###begin p 5
Spinal cord injury induces the proliferation of putative stem cells derived from the ependyma that migrate towards the site of injury. Ependymal cell progeny differentiate and give rise to astrocytes as well as myelinating oligodendrocytes.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b001">1</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b002">2</xref>
Transplantation of different types of stem cells improves functional recovery after spinal cord injury in rodents and primates. The beneficial effects appear to be mediated by several mechanisms, including replacement of lost cells, secretion of neurotrophic factors, and probably most importantly, the generation of oligodendrocytes that remyelinate spared axons in the vicinity of a lesion [1,2].
###end p 7
###begin p 8
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b003">3</xref>
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b004">4</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b005">5</xref>
###xml 770 771 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b006">6</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b007">7</xref>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b008">8</xref>
###xml 859 860 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b009">9</xref>
Neural stem cells present in the adult spinal cord can be propagated in vitro [3,4], and promote functional recovery when transplanted to the injured spinal cord [5]. Endogenous neural stem cells could therefore be attractive candidates to manipulate for the production of desired progeny after spinal cord injury as an alternative to stem cell transplantation. This approach would offer a noninvasive strategy that avoids the need for immune suppression, but has been held back by difficulties in identifying adult spinal cord neural stem cells and developing rational ways to modulate their response to injury. Studies using indirect techniques have suggested that the neural stem cell potential in the adult rodent spinal cord resides in the white matter parenchyma [6,7] or close to the central canal, either in the ependymal layer [8] or subependymally [9].
###end p 8
###begin p 9
We have employed genetic fate mapping to characterize a candidate neural stem cell population in the adult spinal cord and show that close to all in vitro neural stem cell potential resides within the population of ependymal cells. Ependymal cells give rise to a substantial proportion of scar-forming astrocytes as well as to some myelinating oligodendrocytes after spinal cord injury. Modulating the fate of ependymal cell progeny after injury could potentially promote the generation of cell types that may facilitate recovery after spinal cord injury.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Genetic Labeling of Cells in the Adult Spinal Cord Ependymal Layer
###end title 11
###begin p 12
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1</italic>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b010">10</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b013">13</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b014">14</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b010">10</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b013">13</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b015">15</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b019">19</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b020">20</xref>
###xml 823 829 823 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin</italic>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b021">21</xref>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
In order to fate map candidate neural stem cells close to the central canal, we generated two transgenic mouse lines expressing tamoxifen-dependent Cre recombinase (CreER) under the control of FoxJ1 (HFH4) or Nestin regulatory sequences. FoxJ1 expression is specific to cells possessing motile cilia or flagella [10-13]. In the adult forebrain, a subset of astrocytes in the subventricular zone contact the ventricle and have an immotile primary cilium [14], but FoxJ1 expression is restricted to cells with motile cilia [10-13]. Nestin is expressed in central nervous system stem and progenitor cells during development and in adulthood [15-19]. In the adult spinal cord, nestin is expressed by cells lining the central canal, endothelial cells, and sparse white matter glial cells [20]. The second intron enhancer in the Nestin gene allows for selective expression of CreER in the neural lineage [21], eliminating expression in for example endothelial cells.
###end p 12
###begin p 13
###xml 99 110 99 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 115 127 115 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">Figure 1</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b022">22</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b023">23</xref>
###xml 441 450 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg001">Figure S1</xref>
###xml 750 758 743 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">Figure 1</xref>
###xml 760 761 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">1</xref>
###xml 810 822 801 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 845 856 834 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 897 898 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 917 922 <span type="species:ncbi:10090">mouse</span>
CreER expression in the adult spinal cord is limited to cells lining the central canal in both the FoxJ1-CreER and Nestin-CreER mouse lines (Figure 1). Administration of tamoxifen to mice on an R26R [22] or Z/EG [23] Cre reporter background allows inducible, permanent. and heritable genetic labeling by the expression of beta-galactosidase (beta-gal; R26R) or GFP (Z/EG) in cells expressing CreER (the strategy is schematically depicted in Figure S1). Recombination in the absence of tamoxifen was exceptionally rare (<1 cell/30 coronal 20-mum-thick sections in both transgenic lines) and limited to CreER-expressing cells in the ependymal layer. Administration of tamoxifen (five daily injections) resulted in recombination of the reporter allele (Figure 1A-1D) in 82 +/- 4% of transgene-expressing cells in Nestin-CreER mice and 88 +/- 4% in FoxJ1-CreER mice (mean +/- standard deviation [SD], n = 6 mice for each mouse line).
###end p 13
###begin title 14
Genetic Labeling of Spinal Cord Ependymal Cells
###end title 14
###begin p 15
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1</italic>
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin</italic>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice with tamoxifen-inducible Cre recombinase (CreER) under the control of the FoxJ1 promoter (A and B) or the Nestin second intron enhancer (C and D) drive expression and induce recombination after 5 daily tamoxifen injections (resulting in beta-gal expression) in cells lining the central canal in the adult spinal cord.
###end p 15
###begin p 16
(A and C) Overviews of coronal sections from the thoracic spinal cord and (B and D) higher magnification of the central canal region demonstrating recombination in the majority of cells and cytoplasmic CreER protein 6 days after the last tamoxifen administration. Cell nuclei are visualized with DAPI in (A and C). Scale bars indicate 100 mum in (A) and (C), and 25 mum in (B) and (D).
###end p 16
###begin title 17
Phenotypic Characterization of Adult Spinal Cord Ependymal Cells
###end title 17
###begin p 18
###xml 65 77 65 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 81 92 81 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 161 170 161 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg002">Figure S2</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b015">15</xref>
###xml 334 344 334 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg002">Figures S2</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg003">S3</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b024">24</xref>
###xml 661 671 657 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg002">Figures S2</xref>
###xml 676 678 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg003">S3</xref>
The cells at the central canal expressing CreER protein from the Nestin-CreER or FoxJ1-CreER transgene are immunoreactive to Crocc, a marker for ciliated cells (Figure S2). They contain the intermediate filaments nestin and vimentin, associated with immature neural cells [15], but notably not glial fibrillary acidic protein (GFAP) (Figures S2 and S3), which is present in some neural stem cells in the adult forebrain [24]. The transgene expressing cells display other markers associated with neural stem/progenitor cells such as CD133/prominin-1, Musashi1, PDGFR-alpha, Sox2, Sox3, and Sox9 but are negative for the oligodendroglial progenitor marker Olig2 (Figures S2 and S3). All above-mentioned proteins appear uniformly expressed by the cells lining the central canal, and we have not found any molecular marker delineating any subpopulations.
###end p 18
###begin p 19
###xml 47 59 47 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 64 75 64 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 290 299 290 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">Figures 2</xref>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">2</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg004">S4</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg005">S5</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b025">25</xref>
###xml 551 560 551 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">Figures 2</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">2</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg004">S4</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg005">S5</xref>
###xml 815 824 815 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">Figures 2</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">2</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg005">S5</xref>
###xml 1005 1014 1005 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">Figures 2</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg005">S5</xref>
###xml 1162 1170 1162 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g002">Figure 2</xref>
###xml 1176 1184 1176 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-st001">Table S1</xref>
Immunoelectron microscopy established that the Nestin-CreER and FoxJ1-CreER transgenes are expressed in identical cell populations by the central canal; their expression is restricted to lumen-contacting cells with motile cilia (9 + 2 axonemes), and all such cells express both transgenes (Figures 2A-2C, S4, and S5). Ultrastructural analysis in serial sections revealed morphological heterogeneity among the lumen-contacting ciliated cells, with some cells displaying typical cuboidal ependymal cell morphology and others a tanycyte morphology [25] (Figures 2C, 2D, S4, and S5). In addition, there is a less numerous third cell type, which we refer to as a radial ependymal cell. Radial ependymal cells share the morphology of the cytoplasm, and often nucleus, with ependymal cells, but have a long basal process (Figures 2B, 2D, and S5). The radial ependymal cells almost invariably reside in the dorsal or ventral pole of the ependymal layer, with a basal process oriented along the dorsoventral axis (Figures 2A and S5). Although the lumen-contacting ciliated cells can be subdivided into these three groups, cells with intermediary phenotypes are frequent (Figure 2E and Table S1), which together with their homogeneous molecular profile suggests that they are closely related. The naming of ependymal cell types is based solely on morphological criteria and does not imply any function. The central canal-contacting ciliated cells have in common that they reside in the ependymal layer, thus we collectively refer to them as ependymal cells.
###end p 19
###begin title 20
Characterization of Spinal Cord Ependymal Cells
###end title 20
###begin p 21
###xml 58 69 58 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
(A-C) Immunoelectron microscopy of the central canal in a FoxJ1-CreER mouse. Pseudocoloring in (A) illustrates the localization of CreER-immunoreactive radial ependymal cells (B), cuboidal ependymal cells, and tanycytes (C).
###end p 21
###begin p 22
(D) Table with color code for (A-C), describing the characteristics of the three cell types that line the central canal.
###end p 22
###begin p 23
###xml 144 154 144 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg004">Figures S4</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg005">S5</xref>
###xml 167 175 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-st001">Table S1</xref>
(E) Venn diagram illustrating the percentage of cuboidal ependymal cells, tanycytes, radial ependymal cells, and intermediate morphologies (see Figures S4 and S5, and Table S1 for details on the ultrastructural analysis). Scale bars indicate 10 mum in (A) and 3 mum in (B) and (C).
###end p 23
###begin title 24
Adult Spinal Cord Stem Cells Are Largely Contained within the Ependymal Cell Population
###end title 24
###begin p 25
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b003">3</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b006">6</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b009">9</xref>
###xml 289 300 289 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 305 317 305 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 527 535 527 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b026">26</xref>
###xml 739 747 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">Figure 1</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">1</xref>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 937 949 935 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 971 982 967 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 1067 1068 1061 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1108 1116 1102 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 1122 1123 1116 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">3</xref>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 628 633 <span type="species:ncbi:10090">mouse</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1073 1077 <span type="species:ncbi:10090">mice</span>
Adult spinal cord neural stem cells can be propagated in vitro [3], but their precise identity has been difficult to establish unequivocally [6-9]. We utilized our genetic labeling paradigms to ask whether adult spinal cord ependymal cells have neural stem cell properties in vitro. Adult FoxJ1-CreER and Nestin-CreER mice on Cre recombination reporter background (R26R or Z/EG) received five daily injections of tamoxifen to induce recombination, and primary cultures were initiated after an additional 6 d without tamoxifen (Figure 3A). Tamoxifen and its active metabolite 4-hydroxytamoxifen have a half-life of 6-12 h in the mouse [26], and accordingly CreER protein was no longer detectable in the nucleus after 6 d without tamoxifen (Figure 1B and 1D). Spinal cords were dissociated and plated at clonal density in standard conditions that allow for neurosphere formation (Figure 3B). We found that 76 +/- 5.7% of neurospheres from Nestin-CreER and 85 +/- 2.2% from FoxJ1-CreER mice were recombined and thus derived from recombined ependymal cells (mean +/- SD, n = 6 mice analyzed separately per line, Figure 3C and 3E). Neurospheres were either homogeneously recombined or not recombined, verifying their clonal origin.
###end p 25
###begin title 26
Ependymal Cells Display Neural Stem Cell Properties In Vitro
###end title 26
###begin p 27
(A) Schematic depiction of tamoxifen administration paradigm and (B) analysis of neural stem cell properties and in vivo and in vitro recombination frequency.
###end p 27
###begin p 28
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
(C) The high proportion of recombined (rec.) neurospheres (mean + SD, n = 6 mice for each transgenic mouse line) demonstrates that the majority derives from ependymal cells.
###end p 28
###begin p 29
(D) Estimate of the proportion of neurospheres that derive from ependymal cells by normalization to the recombination rate in tissue sections of the spinal cords that were used to initiate the cultures (mean +/- SD).
###end p 29
###begin p 30
###xml 41 52 41 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
(E) Recombined primary neurospheres from FoxJ1-CreER mice on R26R background visualized by X-gal staining (arrow points to one unrecombined neurosphere).
###end p 30
###begin p 31
(F) Differentiation of a clonally derived recombined neurosphere into neurons (betaIIItub), astrocytes (GFAP), and oligodendrocytes (O4).
###end p 31
###begin p 32
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 85 74 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
(G) Flow cytometric isolation of GFP+ cells from the spinal cord of adult FoxJ1-CreER mice based on the IRES-GFP signal (GFP gate). 7-AAD labels dead cells, which were excluded.
###end p 32
###begin p 33
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 144 145 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
(H-K) Brightfield (BF) and fluorescent images (I and K) of a single GFP+ sorted cell and a neurosphere (J) formed from such a cell, which is GFP- due to the lack of FoxJ1 expression (K).
###end p 33
###begin p 34
Scale bars indicate 400 mum in (E), 20 mum in (F), 100 mum in (H) and (I), and 50 mum in (J) and (K).
###end p 34
###begin p 35
###xml 831 839 831 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 1104 1112 1104 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
Since recombination never was fully penetrant in the ependymal cells, the analysis of the proportion of neurospheres that were recombined may underestimate the true contribution of this cell population to neurosphere formation. If there is a stochastic distribution of recombination within the CreER expressing cell population, rather than recombination demarcating a subpopulation that differs with regard to neurosphere-forming potential, one can estimate the contribution of the cell population to neurosphere formation by normalizing it to the observed recombination rate. To estimate the theoretically maximal proportion of neurosphere-initiating cells that are ependymal cells, we analyzed the recombination frequency in CreER-expressing cells in sections from each spinal cord sample that was used for neurosphere cultures (Figure 3B). Normalizing the recombination frequency in neurospheres to the recombination frequency in the CreER-expressing cells in vivo, suggested that close to all neurosphere-initiating potential could reside within the ependymal cell population under these conditions (Figure 3D).
###end p 35
###begin p 36
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b027">27</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b028">28</xref>
###xml 231 243 231 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 248 259 248 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg006">Figure S6</xref>
###xml 690 698 690 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 367 382 <span type="species:ncbi:10090">transgenic mice</span>
Progenitor cells with limited self-renewal capacity can give rise to neurospheres, but are incapable of generating new neurospheres when passaged more than twice [27,28]. We found that 100% of the recombined neurospheres from both Nestin-CreER and FoxJ1-CreER could be serially passaged at least eight times to give rise to new neurospheres (n = 6 neurospheres per 4 transgenic mice). The number of cells increased exponentially during passaging (Figure S6). Analysis of the differentiation potential of ependymal cell-derived neurospheres after three passages revealed that 100% of the neurosphere clones were multipotent and differentiated into neurons, astrocytes, and oligodendrocytes (Figure 3F).
###end p 36
###begin p 37
###xml 233 242 233 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figures 3</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg001">S1</xref>
###xml 422 423 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 438 439 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 476 477 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 515 523 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 525 526 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">3</xref>
###xml 618 619 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 431 436 <span type="species:ncbi:10090">mouse</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
We also isolated prospectively identified ependymal cells by flow cytometry independently of Cre-mediated recombination by utilizing the green fluorescent protein (GFP) expression under the bicistronic control of the FoxJ1 promoter (Figures 3G and S1). Flow cytometric isolation of adult spinal cord cells substantially reduced neurosphere formation, and 0.18 +/- 0.06% (mean +/- SD from in average 1,600 GFP-positive (GFP+) cells/mouse, n = 6 mice analyzed separately) of GFP+ ependymal cells formed neurospheres (Figure 3H-3K). In contrast, not a single neurosphere developed from the same number of cells in the GFP- non-ependymal fraction from any animal in the same experiments. Thus, the neural stem cell potential in the adult spinal cord, at least under the conditions employed here, largely resides within the ependymal cell population.
###end p 37
###begin title 38
Ependymal Cells Self-Renew In Vivo
###end title 38
###begin p 39
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b008">8</xref>
###xml 324 332 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">Figure 4</xref>
###xml 338 339 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">4</xref>
###xml 685 693 677 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">Figure 4</xref>
###xml 699 700 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">4</xref>
###xml 821 832 813 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 837 849 829 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
Cells in the adult spinal cord ependymal layer proliferate, albeit slowly or rarely [8]. Continuous administration for one month in the drinking water of 5-bromo-2-deoxyuridine (BrdU), which is incorporated into DNA in cells in S-phase, resulted in labeling of 19.9 +/- 4.2% of ependymal cells (mean +/- SD from three mice, Figure 4A and 4B). The BrdU-labeled ependymal cells constituted 4.8 +/- 0.9% of all BrdU-labeled cells in a spinal cord segment (mean +/- SD from three mice). The majority of BrdU-labeled ependymal cells were found in pairs, indicating that most mitoses resulted in self-duplication rather than the generation of another cell that had left the ependymal layer (Figure 4A and 4B). In line with this, analysis of the distribution of recombined cells up to 8 mo after tamoxifen administration in the FoxJ1-CreER and Nestin-CreER mice did not provide evidence for the generation of cells that leave the ependymal layer under normal conditions (unpublished data).
###end p 39
###begin title 40
Ependymal Cells Self-Renew In Vivo
###end title 40
###begin p 41
(A and B) BrdU incorporation in ependymal cells after 4-wk administration in the drinking water. Many of the labeled cells are found in pairs (arrowheads).
###end p 41
###begin p 42
(A) shows a coronal and (B) a sagittal section.
###end p 42
###begin p 43
###xml 152 156 <span type="species:ncbi:10090">mice</span>
(C-E) The recombination (rec.) rate of ependymal cells remains at the same level from 2 d to 10 mo after tamoxifen administration (mean and SD from 3-4 mice at each time point).
###end p 43
###begin p 44
The scale bar indicates 25 mum in (A-D).
###end p 44
###begin p 45
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b029">29</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b030">30</xref>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">Figure 4</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">4</xref>
Whether a specific cell population is derived from another cell type or it is maintained through self-duplication can be established by analyzing the genetic labeling frequency at different time points after induction of recombination [29,30]. There was no reduction in the proportion of recombined ependymal cells for up to 10 mo after tamoxifen administration (Figure 4C-4E), indicating that ependymal cells are maintained by self-renewal and are not replenished by another cell population.
###end p 45
###begin title 46
Ependymal Cells Are Activated by Spinal Cord Injury
###end title 46
###begin p 47
###xml 118 126 118 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 336 347 336 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 351 363 351 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b020">20</xref>
###xml 658 667 658 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">Figures 5</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">5</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg007">S7</xref>
###xml 919 927 919 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">Figure 5</xref>
###xml 929 930 929 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">5</xref>
###xml 1089 1094 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1</italic>
###xml 1105 1113 1105 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 1211 1219 1211 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">Figure 5</xref>
###xml 1222 1223 1222 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">5</xref>
###xml 1230 1231 1230 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">5</xref>
###xml 1416 1424 1416 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">Figure 5</xref>
###xml 1430 1431 1430 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">5</xref>
We next assessed the response of ependymal cells to spinal cord injury. We used the same labeling paradigm as before (Figure 3A), with a 6-d period between the last tamoxifen dose and the injury. This ensures that all recombination occurs prior to the insult and that even if other cells than ependymal cells would start to express the FoxJ1-CreER or Nestin-CreER transgene in response to the injury (nestin is indeed expressed by reactive astrocytes [20]), it would not result in recombination. An incision in the dorsal funiculus, which does not compromise the integrity of the ependymal layer, dramatically increased the proliferation of ependymal cells (Figures 5A, 5B, and S7). In contrast to the uninjured spinal cord, where proliferation of ependymal cells appears largely limited to self-renewing divisions, recombined cells started to migrate and were located outside the ependymal layer 4 d after the injury (Figure 5C-5I). Migrating recombined cells lost their ependymal phenotype as judged by the loss of immunoreactivity to Sox2 and Sox3 and lack of CreER expression from the FoxJ1 promoter (Figure 3D and unpublished data). Most emigrating cells expressed Sox9 and some the astrocyte marker GFAP (Figure 5F, 5H, and 5I). Ultrastructural analysis revealed that ependymal cell morphology was largely unaltered by the injury, with the exception of a darker cytoplasm due to a higher content of filaments (Figure 5J and 5K).
###end p 47
###begin title 48
Ependymal Cells Are Activated by Injury
###end title 48
###begin p 49
###xml 684 695 684 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 696 701 <span type="species:ncbi:10090">mouse</span>
Uninjured and adjacent injured segments from mice 4 d after a dorsal funiculus incision. Recombined cells leave the ependymal layer in the injured segments (arrowheads). (A and B) Ki67 immunoreactivity indicates ependymal proliferation in the injured, but not in the uninjured segment. Migrating recombined cells lose Sox3 expression (D), but most are Sox9 immunoreactive, and a smaller population is GFAP immunoreactive (F-I). Some ependymal cells within the ependymal layer (outlined by hatched line in [I]) become GFAP immunoreactive (arrows). (J and K) Electron micrographs of an extended ependymal cell with a dense filamentous matrix (f) in the cytoplasm 4 wk after injury in a FoxJ1-CreER mouse. n, nucleus.
###end p 49
###begin p 50
Scale bars indicate 25 mum in (A-H), 10 mum in (I), 1.5 mum in (J), and 0.2 mum in (K).
###end p 50
###begin title 51
Ependymal Cells Contribute to Scar Formation after Injury
###end title 51
###begin p 52
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 333 344 329 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 677 685 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 691 692 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 807 816 803 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">Figures 5</xref>
###xml 818 819 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g005">5</xref>
###xml 825 826 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 828 829 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 1066 1075 1062 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg008">Figure S8</xref>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
Ependymal progeny migrated towards the injury site in the dorsal funiculus and an increasing number of recombined cells accumulated in the forming glial scar over several weeks and remained there for at least 10 mo after the insult (Figure 6A-6C). The recombined ependyma-derived cells occupied 18.3 +/- 6.9% (mean +/- SD from three FoxJ1-CreER mice) of the area in the scar tissue 2 wk after the injury, which is likely to be a slight underestimate of the true contribution since recombination never was fully penetrant. The ependyma-derived cells were not evenly distributed throughout the injury site, but the scar consisted of patches of recombined and unrecombined cells (Figure 6H and 6I). The reaction of the ependymal cells was restricted to the injured segment and was absent in adjacent segments (Figures 5A-5H and 6A-6C), which are indirectly affected by the severance of axons and Wallerian degeneration. There were no recombined cells outside the ependymal layer in animals in which only the spinal cord was exposed but no lesion was made (sham lesion, Figure S8), and a lesion did not induce recombination in animals that had not received tamoxifen (unpublished data).
###end p 52
###begin title 53
Ependymal Cells Contribute to Scar Formation after Spinal Cord Injury
###end title 53
###begin p 54
(A) Distribution of beta-gal-immunoreactive ependyma-derived cells in coronal sections from an uninjured segment (left) further towards the lesion epicenter (right).
###end p 54
###begin p 55
(B and C) Sagittal sections show the distribution of recombined cells 1 mo (B) and 10 mo (C) after a dorsal funiculus incision (indicated by hatched lines).
###end p 55
###begin p 56
(D and E) Recombined cells outside the ependymal layer display either (D) the astrocytic marker GFAP or (E) a Sox9/vimentin double-positive profile.
###end p 56
###begin p 57
(F and G) Other recombined cells are Olig2 immunoreactive (arrowheads) and have oligodendrocyte morphology at later time points ([F] is at 1 mo and [G] 10 mo).
###end p 57
###begin p 58
(H and I) The scar tissue is compartmentalized with patches of ependyma-derived cells.
###end p 58
###begin p 59
(J and K) Electron micrographs of beta-gal-immunoreactive cells with astrocyte (J) or oligodendrocyte (K) morphology. Boxed areas are shown at a higher magnification in the insets.
###end p 59
###begin p 60
(L) Drawing (based on [C]) depicting the distribution of recombined cells of different phenotypes.
###end p 60
###begin p 61
###xml 76 80 <span type="species:ncbi:10090">mice</span>
(M) Marker profile of recombined ependyma-derived cells (mean and SD from 3 mice at each time point) in the area encompassing the injury indicated by hatched lines in (L).
###end p 61
###begin p 62
c, caveolae; f, filaments; ld, lipid droplet; n, nucleus.
###end p 62
###begin p 63
Scale bars indicate 25 mum in (D-G) and (H), 50 mum in (I), 2 mum in (J), 1 mum in (K), and 0.15 mum in insets in (J) and (K).
###end p 63
###begin p 64
###xml 470 479 470 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg008">Figure S8</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b031">31</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b032">32</xref>
###xml 1134 1143 1134 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg009">Figure S9</xref>
Since some ependymal cells extend processes along the dorsolateral midline, it was possible that the activation of ependymal cells by a dorsal funiculus incision was triggered by the severance of such processes. To investigate this, we performed incisions in the lateral spinal cord, which do not directly injure the ependymal cell processes in the dorsolateral midline. In these animals, ependymal cell progeny were generated and migrated laterally towards the injury (Figure S8). The ependyma-derived cells migrating to the lesion appeared less numerous after a lateral than after a dorsal incision, suggesting that severance of ependymal cell processes in the midline is not necessary for the activation of ependymal cells, but that it may augment their reaction. The migration of ependyma-derived cells to the site of injury suggests the presence of attractive signals originating in the lesion area. SDF1, through its receptor CXCR4, mediates attraction of progeny from neural stem/progenitor cells after some types of injuries [31,32]. The majority of ependymal cells as well as their progeny were, however, negative for CXCR4 (Figure S9), making it unlikely that this receptor mediates the attraction of ependymal cell progeny to a spinal cord lesion.
###end p 64
###begin p 65
###xml 236 245 236 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figures 6</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 264 267 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg010">S10</xref>
###xml 417 425 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 554 562 554 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 681 690 681 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figures 6</xref>
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg010">S10</xref>
###xml 831 832 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 841 842 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 895 896 895 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 903 904 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Analysis of the fate of the ependymal cell progeny by molecular markers and electron microscopy after a dorsal funiculus incision revealed that the majority were immunoreactive to Sox9 and vimentin and had an astrocyte-like morphology (Figures 6E, 6H, 6J, 6M, and S10). A smaller subpopulation of the recombined cells expressed GFAP and nestin, but the vast majority of cells with this phenotype were not recombined (Figure 6D, 6H, 6I, and 6M). Recombined GFAP- and nestin-expressing cells were typically located close to the surface of the spinal cord (Figure 6D, 6H, 6I, and 6L), whereas the Sox9- and vimentin-expressing cells were most abundant in the core of the scar tissue (Figures 6L and S10). We conclude that the glial scar is comprised of two different populations of astrocyte-like cells, where the majority of the Sox9+/vimentin+ population derives from ependymal cells and the GFAP+/nestin+ cells are mainly reactive resident astrocytes.
###end p 65
###begin p 66
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 487 495 487 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">6</xref>
###xml 841 850 841 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg008">Figure S8</xref>
We further investigated the contribution of ependymal cells to other lineages. None of the recombined cells in the scar tissue had neuronal morphology or were immunoreactive to the neuron-specific epitope NeuN (unpublished data). A population of recombined cells expressed Olig2 (Figure 6F and 6G). The first month after injury, Olig2-expressing recombined cells were scattered throughout the injury site and had an ultrastructural morphology corresponding to immature oligodendrocytes (Figure 6F, 6K, 6L, and 6M). At later time points, Olig2-expressing ependyma-derived cells were excluded from the scar tissue and were restricted to the uninjured tissue that bordered the scar (Figure 6G, 6L, and 6M). Lesions in the lateral funiculus resulted in the generation of ependymal progeny of the same fates as after a dorsal funiculus incision (Figure S8).
###end p 66
###begin title 67
Relationship between Ependymal Cell Progeny, Extracellular Matrix Molecules, and Axons in Spinal Cord Scar Tissue
###end title 67
###begin p 68
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b033">33</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b034">34</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b035">35</xref>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">Figure 7</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
The scar tissue that forms at spinal cord injuries is thought to inhibit axonal growth [33,34]. Chondroitin sulphate proteoglycans (CSPG) appear to be the principal axonal growth inhibiting molecules in glial scars [35]. Ependyma-derived cells at the injury formed a complementary nonoverlapping pattern with areas that were CSPG immunoreactive (Figure 7A and 7B), indicating that ependymal cell progeny do not contribute to the production of axonal growth-inhibiting CSPG.
###end p 68
###begin title 69
Relationship between Ependymal Cell-Derived Progeny, Axonal Growth-Modulating Molecules, and Axons in the Scar Tissue
###end title 69
###begin p 70
###xml 578 579 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A-E) Chondroitin sulphate proteoglycans (CSPG), which are axonal growth inhibitory, are abundant in the scar tissue 2 wk after a dorsal funiculus lesion. CSPG are present in a complementary and nonoverlapping pattern to beta-gal-expressing ependyma-derived cells. The extracellular matrix proteins fibronectin (A) and laminin (B and F), which are permissive to axonal sprouting, are widely distributed within the scar tissue and overlap with beta-gal-expressing ependyma-derived cells. (C-H) Neurofilament (NF)-immunoreactive axons in the scar tissue are rarely present in CSPG+ areas (C-E) but are associated with ependymal cell progeny (C-H) and laminin (F-H) in the core of the forming scar tissue 2 wk after injury. Scale bars indicate 100 mum.
###end p 70
###begin p 71
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b036">36</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b037">37</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b038">38</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b039">39</xref>
###xml 660 668 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">Figure 7</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
###xml 814 822 814 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">Figure 7</xref>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b039">39</xref>
###xml 1210 1218 1210 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">Figure 7</xref>
###xml 1220 1221 1220 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
###xml 1297 1305 1297 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">Figure 7</xref>
###xml 1308 1309 1308 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
###xml 1312 1313 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
###xml 1320 1321 1320 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g007">7</xref>
In parallel with the production of axonal growth-inhibiting factors in the glial scar, there is an increase in some axonal growth-promoting molecules, such as the extracellular matrix molecules laminin and fibronectin [36,37]. In the injury model employed here, axons send sprouts into the scar tissue, mainly during the first month after an injury, and the axons are preferentially associated with areas in the scar tissue that have high levels of laminin [38,39]. Both laminin and fibronectin immunoreactivity were widely distributed throughout the scar tissue, overlapping both with CSPG-immunoreactive domains and areas occupied by ependyma-derived cells (Figure 7A and 7B). Neurofilament-immunoreactive axons were present in the center of the scar tissue and were often wiggly and oriented in all directions (Figure 7C-7H). This is in contrast to the rostrocaudal orientation of axons seen in the uninjured dorsal funiculus, suggesting that many of the axons present in the scar were severed and sprouting into the scar tissue [39]. Neurofilament-immunoreactive axons were present in domains dominated by ependyma-derived cells, as well as in other areas of the scar where these cells were less abundant (Figure 7C-7H). Axons were often present in direct proximity to ependyma-derived cells (Figure 7D, 7E, 7G, and 7H). The finding that ependyma-derived progeny is not associated with the main scar-associated axonal growth-inhibiting factor, CSPG, together with their proximity to axonal sprouts, argues against these cells being a major factor in glial scar-associated axonal growth inhibition.
###end p 71
###begin title 72
Ependymal Cells Generate Oligodendrocytes after Injury
###end title 72
###begin p 73
###xml 148 156 148 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
###xml 573 581 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g008">Figure 8</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g008">8</xref>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 777 785 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g008">Figure 8</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g008">8</xref>
The finding that some ependymal cell progeny displayed a marker profile and ultrastructural morphology suggesting oligodendroglial differentiation (Figure 6) prompted us to characterize these cells further and to address whether they may contribute to axonal remyelination at later time points. Ten months after spinal cord injury, the majority of ependyma-derived progeny are located in the scar tissue that has formed at the injury site, but a substantial number of cells are sparsely distributed in a large area of the intact grey and white matter bordering the lesion (Figure 8A-8C). Most of these cells are Olig2+ and display mature oligodendrocyte morphology with processes that extend along and enwrap myelin basic protein (MBP)-immunoreactive myelin ensheathing axons (Figure 8B-8D).
###end p 73
###begin title 74
Ependymal Cells Give Rise to Oligodendrocytes after Injury
###end title 74
###begin p 75
(A) Ependymal cell-derived progeny are most abundant within the core of the scar tissue forming at the injury (arrow). Ependyma-derived cells are also found, more sparsely, over a larger area in the intact tissue bordering the lesion (arrowheads), where they are associated with myelin basic protein (MBP)-immunoreactive myelin ensheathing neurofilament (NF)-immunoreactive axons.
###end p 75
###begin p 76
(B-D) Ependymal cell-derived progeny harboring an oligodendrocytic morphology are found both in the grey (B) and white matter (C), and some recombined processes wrap around myelinated axon (D).
###end p 76
###begin p 77
Scale bars indicate 100 mum in (A), 25 mum in (B) and (C), and 10 mum in (D).
###end p 77
###begin p 78
###xml 130 139 130 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g009">Figures 9</xref>
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg011">S11</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b025">25</xref>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g009">Figure 9</xref>
###xml 648 656 648 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g009">Figure 9</xref>
###xml 760 768 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g009">Figure 9</xref>
Nuclear regions and processes of two ependyma-derived cells were followed in the electron microscope in serial utrathin sections (Figures 9 and S11, and unpublished data). They both displayed a typical mature oligodendrocyte morphology [25], such as oval nuclei with clumped chromatin, a cytoplasmic matrix that appeared denser than in surrounding astrocytes, a granular endoplasmic reticulum represented by several short cysternae, and tight junctions with adjacent oligodendrocyte processes (Figure 9). Few processes emerged from the cell body, and unlike those of astrocytes, they did not form many branches and did not contain evident fibrils (Figure 9). The processes of the recombined cells could be traced along axons, surrounding their myelin sheaths (Figure 9D). Thus, in addition to the generation of astrocytes, ependymal cells generate myelinating oligodendrocytes.
###end p 78
###begin title 79
Ultrastructure of an Ependyma-Derived Oligodendrocyte
###end title 79
###begin p 80
Electron micrograph of an ependyma-derived beta-gal-expressing cell in the nuclear plane 10 mo after injury (nucleus labeled with asterisk in [A]). (A) The cell displays ultrastructural characteristics of a mature oligodendrocyte such as a denser cytoplasm with fewer intermediate filaments than that of a neighboring astrocyte (As), (B) tight junctions (tj) between the cell body, and an oligodendrocyte process of another cell and (C) granular endoplasmic reticulum (er) cycternae in the perikaryon. Ax, axon; f, filamentous matrix.
###end p 80
###begin p 81
(D) A process (p) of the cell adjacent to the myelin sheath on an axon.
###end p 81
###begin p 82
Scale bars indicate 1 mum in (A) and 250 nm in (C) and (D).
###end p 82
###begin title 83
Discussion
###end title 83
###begin p 84
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b006">6</xref>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b009">9</xref>
Stem cells are notoriously difficult to identify, and their localization in the adult spinal cord has been controversial [6-9]. We report that ependymal cells constitute the vast majority of cells displaying in vitro neural stem cell properties in the adult spinal cord. Ependymal cells self-renew in vivo, but do not generate appreciable numbers of other cell types under homeostatic conditions. Their normally limited proliferation increases dramatically after spinal cord injury and they then produce oligodendrocytes, and more abundantly, astrocytes that migrate to the site of injury and make a substantial part of the glial scar.
###end p 84
###begin p 85
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b040">40</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b041">41</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b042">42</xref>
###xml 636 644 <span type="species:ncbi:405018">cardinal</span>
The immediate descendants of tissue stem cells, progenitor cells with limited self-renewal capacity and/or lineage potential, can in some situations acquire stem cell properties [40]. For example, spermatogonial progenitor cells can regain stem cell function after injury and during aging and forebrain neurospheres may be derived from committed progenitors [41,42]. It appears unlikely that this would explain the neural stem cell properties displayed by ependymal cells in vitro, as they are not replenished by any other cell type in the adult, but are self-renewing. However, although ependymal cells at the population level display cardinal stem cell features in vivo, such as self-renewal and generation of diverse progeny, it is difficult to study these properties at the single cell level in the tissue, and we cannot conclude that they act as stem cells in vivo.
###end p 85
###begin p 86
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b006">6</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b043">43</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b046">46</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b006">6</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b043">43</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b047">47</xref>
###xml 1010 1011 1010 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b006">6</xref>
###xml 1012 1014 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b044">44</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b046">46</xref>
###xml 1074 1075 1074 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In addition to ependymal cells, neural progenitors (expressing NG2, Olig2, and/or Nkx2.2) reside in the white and gray matter of the adult rodent spinal cord [6,43-46]. Different studies have suggested that the parenchymal progenitors represent multipotent neural stem cells or more-restricted glial progenitors [6,43,47]. Under the standard neurosphere assay conditions employed here, the vast majority of the neural stem cell potential resides within the ependymal population. However, we cannot exclude that other cells contribute, to a comparatively smaller degree, to neurosphere formation under our conditions or that they may display neural stem cell properties under other conditions. The parenchymal progenitors are likely to serve to replace glial cells in the uninjured spinal cord, which we do not find evidence that ependymal cells do. Parenchymal progenitors are rapidly depleted after spinal cord injury, but are later replaced and may participate in the generation of glial cells after injury [6,44,46]. It is possible that some of the ependyma-derived Olig2+ cells observed shortly after injury represent regenerated parenchymal progenitors.
###end p 86
###begin p 87
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b048">48</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b049">49</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b050">50</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b053">53</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b035">35</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b036">36</xref>
The limited functional recovery typically associated with central nervous system injuries is in part due to the failure of severed axons to regrow and reinnervate their targets. Axonal regeneration is inhibited by scar formation and growth-inhibitory factors associated with myelin and astrocytes [48,49]. Modulating the responsiveness to axonal growth-inhibitory factors and glial scar formation are attractive strategies to improve functional recovery after central nervous system injuries [50-53]. The majority of ependyma-derived cells differentiate to astrocyte-like cells after injury and are found in the core of the scar tissue. However, these cells are found in complementary nonoverlapping domains to areas immunoreactive to CSPG, the most important axonal growth inhibitor associated with glial scars [35,36]. Moreover, axons in the scar tissue, most likely sprouts from severed axons growing into the scar tissue, were frequently found in direct proximity to ependyma-derived cells. This argues that ependyma-derived cells in the scar tissue do not constitute a major impediment to axonal growth, and may even suggest that they support some local sprouting.
###end p 87
###begin p 88
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b054">54</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b055">55</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b056">56</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b057">57</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b059">59</xref>
###xml 1130 1131 1130 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b005">5</xref>
###xml 1314 1315 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b005">5</xref>
###xml 1404 1412 1404 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 184 187 <span type="species:ncbi:9606">man</span>
Spinal cord injury results in the loss of oligodendrocytes and demyelination of axons even at some distance to the lesion [54,55]. Spinal cord injuries are most commonly incomplete in man, leaving spared tissue connecting the spinal cord above and below the lesion, but the function of remaining axons is often compromised due to demyelination. Without insulating sheaths of myelin, spared axons close to, but not directly affected by the injury, become less efficient in their ability to conduct electrical impulses [56]. Moreover, chronically demyelinated axons are vulnerable to degeneration. Axons are remyelinated with time, and this is thought to occur through the generation of new oligodendrocytes by stem or progenitor cells rather than by self-duplication of mature remaining oligodendrocytes [57-59]. We report here that ependymal cells contribute to the regeneration of oligodendrocytes and remyelination after spinal cord injury. The differentiation pattern of ependymal cells after injury is reminiscent to that seen for in vitro expanded adult spinal cord neural stem cells transplanted to the injured spinal cord [5]. Transplanted adult spinal cord-derived neurospheres improve functional recovery, and if they are forced to generate more oligodendrocytes, functional recovery is further improved [5]. Since ependymal cells are the main source of neurospheres from the adult spinal cord (Figure 3), promoting oligodendrocyte generation from these cells in vivo could potentially improve recovery after spinal cord injury. The development of pharmacological strategies to modulate endogenous stem cells and their progeny may be an attractive alternative to cell transplantation for the treatment of spinal cord injury.
###end p 88
###begin title 89
Materials and Methods
###end title 89
###begin title 90
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Generation of transgenic mice.
###end title 90
###begin p 91
###xml 4 16 4 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nestin</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b018">18</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b060">60</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b061">61</xref>
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b062">62</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b021">21</xref>
###xml 214 225 214 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b013">13</xref>
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 572 574 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 303 318 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:381124">corn</span>
For Nestin-CreER, we used the enhancer found in the second intron of the rat nestin gene fused to a minimal hsp68 promoter [18,60,61] that controls the expression of CreERT2 [62], as previously described [21]. For FoxJ1-CreER, we used a human FOXJ1 promoter [13] fused to a CreERT2 ires-EGFP construct. Transgenic mice were generated at the Karolinska Center for Transgene Technologies by standard procedures utilizing pronuclear injection of CBA x C57BL/six fertilized eggs. Potential founder animals were screened by Southern blot analysis and PCR analysis using a CreERT2-specific fragment as probe or PCR template. Founder mice were bred to wild-type C57Bl/6 mice. Expression of the transgene was analyzed by confocal microscopy of sections stained with anti-Cre antibodies and cell-specific markers. Recombination was induced by five daily intraperitoneal injections of 2 mg of tamoxifen (Sigma; 20 mg/ml in corn oil).
###end p 91
###begin title 92
Immunohistochemistry.
###end title 92
###begin p 93
###xml 1477 1479 1448 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b063">63</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 386 392 <span type="species:ncbi:9793">donkey</span>
###xml 674 679 <span type="species:ncbi:10090">mouse</span>
###xml 880 886 <span type="species:ncbi:9986">rabbit</span>
###xml 917 921 <span type="species:ncbi:9925">goat</span>
###xml 950 953 <span type="species:ncbi:10116">rat</span>
###xml 980 983 <span type="species:ncbi:10116">rat</span>
###xml 1041 1046 <span type="species:ncbi:10090">mouse</span>
###xml 1070 1075 <span type="species:ncbi:10090">mouse</span>
###xml 1110 1116 <span type="species:ncbi:9986">rabbit</span>
###xml 1156 1161 <span type="species:ncbi:10090">mouse</span>
###xml 1201 1207 <span type="species:ncbi:9986">rabbit</span>
###xml 1232 1237 <span type="species:ncbi:10090">mouse</span>
###xml 1275 1281 <span type="species:ncbi:9986">rabbit</span>
###xml 1310 1314 <span type="species:ncbi:9925">goat</span>
###xml 1348 1354 <span type="species:ncbi:9986">rabbit</span>
###xml 1376 1382 <span type="species:ncbi:9986">rabbit</span>
###xml 1415 1418 <span type="species:ncbi:10116">rat</span>
###xml 1469 1475 <span type="species:ncbi:9986">rabbit</span>
###xml 1491 1496 <span type="species:ncbi:10090">mouse</span>
###xml 1544 1551 <span type="species:ncbi:9031">chicken</span>
###xml 1611 1616 <span type="species:ncbi:10090">mouse</span>
###xml 1638 1643 <span type="species:ncbi:10090">mouse</span>
###xml 1667 1671 <span type="species:ncbi:9925">goat</span>
###xml 1706 1712 <span type="species:ncbi:9986">rabbit</span>
###xml 1748 1752 <span type="species:ncbi:9925">goat</span>
###xml 1787 1794 <span type="species:ncbi:9031">chicken</span>
Adult mice were perfused transcardially with PBS followed by 4% formaldehyde in PBS, spinal cords were post-fixed overnight at 4 degreesC and then cryoprotected in 30% sucrose. Coronal (14 or 20 mum) or sagittal (20 mum, from approximately9-mm-long pieces) sections were collected alternating on ten slides (8-10 sections per slide). Sections were incubated with blocking solution (10% donkey serum in PBS, with 0.3% Triton-X100) for 1 h at room temperature, then incubated at 4 degreesC or room temperature in a humidified chamber for 12-48 h with primary antibodies diluted in blocking solution. For MBP staining, sections were first delipidized. For antibodies raised in mouse, the M.O.M. kit (Vector), ABC kit (Vector), and TSA system (Perkin Elmer) were used following the manufacturers' instructions. The following primary antibodies were used: beta-galactosidase (1:5,000, rabbit; ICN Biomedicals, or 1:1,000, goat; Biogenesis), BrdU, (1:200, rat; Accurate), CD133 (1:500, rat, clone 13A4; eBioscience), chondroitin sulfate (1:1,000, mouse; Sigma), Cre (1:2,000, mouse; Nordic BioSite), Crocc (1:5,000, rabbit, Root6; gift from T.Li), CXCR4 (1:500, mouse; BD Pharmingen), fibronectin (1:1,000, rabbit; Sigma), GFAP (1:1,000, mouse, clone G-A-5; Sigma), Ki67 (1:1,000, rabbit; Neomarkers), Olig2 (1:500, goat; R&D Systems), laminin (1:1,000, rabbit; Sigma), MBP (1:500, rabbit; Chemicon), musashi-1 (1:2,000, rat, clone 14H1; gift from H.Okano), nestin (1:5,000, rabbit [63] or 1:500, mouse; BD Pharmingen), neurofilament heavy (1:1,000, chicken; Chemicon), PDGFRalpha (1:500; BD Pharmingen), RC1 (1:200, mouse; DSHB), Sox2 (1:500, mouse; Chemicon, or 1:1,000, goat; gift from J. Muhr), Sox3 (1:500, rabbit; gift from T.Edlund), Sox9 (1:500, goat; R&D Systems), vimentin (1:1,000, chicken; Chemicon). After washing, antibody staining was revealed using species-specific fluorophore-conjugated (Cy3, Cy5 from Jackson, and Alexa 488 from Molecular Probes) or biotin-conjugated secondary antibodies (Jackson). Biotinylated secondary antibodies were revealed using the ABC kit (Vector Labs) with TSA fluorescent amplification kit (Perkin-Elmer). Sections were counterstained with DAPI (1 mug/ml; Sigma). Control sections were stained with secondary antibody alone. Pictures were taken using a Zeiss Axioplan 2, Zeiss Axiovert 200M or a LSM510 META confocal microscope with Zeiss and Openlab (Improvision) software. Image processing and assembly was performed in ImageJ and Photoshop.
###end p 93
###begin title 94
Immunoelectron microscopy.
###end title 94
###begin p 95
###xml 495 505 491 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg011">Figure S11</xref>
###xml 789 800 785 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 1245 1254 1240 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg006">Figure S6</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 235 241 <span type="species:ncbi:9793">donkey</span>
Anaesthetized mice were perfused transcardially with 4% paraformaldehyde in PBS. The spinal cord was dissected out and post-fixed for 4 h. Sections (60 mum) were immunolabled with Cre or beta-gal antibodies in 0.1% Triton X100 and 10% donkey serum in PBS. A secondary antibody conjugated to biotin was used with an ABC kit (Vector Labs). In some sections, a fluorescent secondary antibody was used, and sections were labeled with DAPI to map the location of the nuclei of the surrounding cells (Figure S11). The sections were post-fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) and in 1% osmium tetraoxide in 0.1 M cacodylate buffer, dehydrated in a graded series of ethanol, stained with uranyl acetate, and embedded in Durcupan resin (Fluka). Serial sections (200 nm) of FoxJ1-CreER spinal cord were used to define the ultrastructural morphology of cells lining the central canal. The complete series of sections from individual cells were traced in 90 sections to characterize the morphology in three dimensions. Serial semi- and ultrathin sections (2 mum and 70 nm, respectively) were used in correlative light and electron microscopic evaluation (CLEM) of the fate of ependyma-derived cells 4 wk after a spinal cord injury (Figure S6). The semithin sections were used to identify immunopositive cells, and the ultrathin sections to show the morphology of the identified cells. Sections (70-200 nm) were placed on Formvar-coated copper grids, counterstained with 2% uranyl acetate and Reynold's lead citrate. Sections were examined in a Tecnai 12 electron microscope (FEI) equipped with 2kx2k TemCam-F224HD camera (TVIPS).
###end p 95
###begin title 96
Neural stem cell cultures.
###end title 96
###begin p 97
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b008">8</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b064">64</xref>
###xml 420 431 420 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26R</italic>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 449 461 449 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26R</italic>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 579 587 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g003">Figure 3</xref>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
Spinal cords were dissected and cells dissociated using papain (Worthington). Neurospheres were cultured as described [8] in DMEM/F12 medium supplemented with B27 and EGF and bFGF (both 10 ng/ml). Approximately 200,000 cells were plated in 10-cm cultures dishes, corresponding to a density of 20 cells/microliter, which allows the generation of clonal neurospheres [64]. For assaying self-renewal and multipotentiality, FoxJ1-CreERxR26R (n = 6) and Nestin-CreERxR26R (n = 6) adult mice were administered with tamoxifen intraperitoneally for 5 d with a washout period of 6 d (see Figure 3). Single spheres were manually collected and split into two wells. One well was used for continuous passaging and subsequent neural stem cell differentiation, whereas the other well was used for X-gal staining. For assaying self-renewal, four clonal recombined neurospheres per animal were manually isolated after 12 d of primary neurosphere formation. All recombined neurospheres were serially passaged eight times. In vitro differentiation by growth factor withdrawal for 10 d was assessed in passage 3 and passage 6 by staining as described above for betaIII-tubulin (Tuj1, 1:1,000; Covance), GFAP (1:5,000; DAKO), and O4 (1:200; Chemicon).
###end p 97
###begin title 98
Flow cytometry.
###end title 98
###begin p 99
###xml 33 44 33 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 231 232 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 333 334 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 371 372 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 519 521 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b065">65</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Spinal cords were dissected from FoxJ1-CreER mice and dissociated using papain (Worthington) and DNase in 1x HBSS at 37 degreesC for 1 h. Ovomucoid inhibitor (Worthington) was added and cells were collected by centrifugation at 300g for 5 min. Cells were resuspended in Leibovitz-15/B27 with 7AAD, which labels dead cells. Single GFP+ (based on the ires-GFP signal), 7AAD- cells were isolated using a FACSAria (BD). Singlets were identified based on forward scatter width (FSC-W) versus forward scatter height (FCS-H) [65]. Single cell sorting and GFP fluorescence was confirmed by microscopic examination.
###end p 99
###begin title 100
Spinal cord injury, BrdU, and growth factor treatments.
###end title 100
###begin p 101
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b039">39</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized with 2.5% Avertin, and the dorsal funiculus at mid-thoracic level was cut transversely and was extended rostrally with microsurgical scissors to span one segment [39]. In other animals, the lateral funiculus was cut transversally and the lesion extended rostrally to span one segment.
###end p 101
###begin p 102
BrdU (1 mg/ml and 1% sucrose, exchanged every 3-4 d) was administered in the drinking water to label dividing cells.
###end p 102
###begin title 103
Quantitative analyses.
###end title 103
###begin p 104
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 169 170 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 178 179 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
In order to correlate recombination frequency in neurosphere cultures to the in vivo recombination frequency of spinal cord tissue, the ratio between CreER+ and beta-gal+ cells (n = 60) was quantified in a small postfixed biopsy from the same spinal cords used for neurosphere cultures.
###end p 104
###begin p 105
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The percentage of BrdU+ ependymal cells was obtained from three animals treated for 4 wk with BrdU in the drinking water (3-5 coronal sections/animal analyzed). The total number of cells per section was obtained counting all nuclei stained with DAPI.
###end p 105
###begin p 106
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 205 222 205 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreERxR26R</italic>
###xml 226 242 226 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreERxR26R</italic>
###xml 268 284 268 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreERxR26R</italic>
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g004">Figure 4</xref>
The in vivo recombination frequency was assessed by counting the number of recombined cells over the total number of ependymal cells (Vimentin+) from five coronal sections per animals at 2 d (4 animals: 2 Nestin-CreERxR26R, 2 FoxJ1-CreERxR26R) and 10 mo (3 animals: 3 FoxJ1-CreERxR26R) after tamoxifen treatment (Figure 4E).
###end p 106
###begin p 107
###xml 126 127 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 198 209 195 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 210 214 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26R</italic>
The contribution of recombined cells at the site of injury was established by measuring the relative area occupied by beta-gal+ cells within the epicenter of the lesion (using ImageJ software) of 3 FoxJ1-CreERxR26R animals (2 sagittal sections per animal) 2 wk after spinal cord injury.
###end p 107
###begin p 108
###xml 276 288 276 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z/EG</italic>
###xml 297 308 297 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26R</italic>
###xml 341 353 341 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z/EG</italic>
###xml 365 376 365 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R26R</italic>
###xml 409 417 409 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g006">Figure 6</xref>
The cell fate distribution of ependyma-derived progeny was obtained by scoring recombined cells positive for Olig2, GFAP or Sox9 in either coronal (3-5 sections per animal) or sagittal (1-2 sections per animal) sections encompassing the lesion site from 1 month (3 animals: 1 Nestin-CreERxZ/EG, 2 FoxJ1-CreERxR26R) and 8-10 mo (4 animals: 1 Nestin-CreERxZ/EG and 3 FoxJ1-CreERxR26R) after spinal cord injury (Figure 6M).
###end p 108
###begin p 109
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 326 342 326 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreERxR26R</italic>
###xml 381 390 381 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0060182-sg007">Figure S7</xref>
The frequency of proliferation of ependymal cells and their progeny was assessed by counting the number of Ki67+ recombined cells over the total number of recombined cells from three segments (rostral to, caudal to, and at the injury site; average of 15 coronal sections, or 300 recombined cells, per segment analyzed) from 2 FoxJ1-CreERxR26R animals 4 d after spinal cord injury (Figure S7C).
###end p 109
###begin title 110
Supporting Information
###end title 110
###begin title 111
Schematic Illustration of Transgenic Constructs and Genetic Labeling Strategy
###end title 111
###begin p 112
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin</italic>
###xml 158 163 <span type="species:ncbi:9606">human</span>
(A) The Nestin 2nd intron central nervous system (CNS)-specific stem/progenitor enhancer (NestinE) with a minimal hsp68 promoter drives CreER expression. The human FoxJ1 promoter drives CreER and EGFP expression in ependymal cells with motile cilia. CreER protein is cytoplasmic due to the association with the heat-shock chaperone complex.
###end p 112
###begin p 113
(B) Nuclear localization of CreER and recombination is induced upon 4-hydroxytamoxifen (4-OHT) binding to the ER domain. The reporter allele consists of a loxP-flanked transcriptional stop cassette. Cre recombination induces the expression of the reporter protein (beta-gal or GFP) under a general and ubiquitous promoter.
###end p 113
###begin p 114
(205 KB TIF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin title 116
Molecular Marker Expression by Adult Spinal Cord Ependymal Cells
###end title 116
###begin p 117
(A-D) Ciliary rootlet coiled-coil protein (Crocc, also known as Rootletin) is expressed in Sox2 (a neural stem cell marker) positive ciliated ependymal cells of the adult spinal cord and colocalizes with beta-gal expression in recombined ependymal cells.
###end p 117
###begin p 118
(E-H) Ependymal cells are immunoreactive to the neural stem cell-associated protein CD133/Prominin, which is localized at the luminal surface (shown in higher magnification in [H]).
###end p 118
###begin p 119
###xml 63 64 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(I-L) Nestin, but not GFAP, is expressed in recombined beta-gal+ ependymal cells.
###end p 119
###begin p 120
###xml 191 207 191 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreERxR26R</italic>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
(M-P) The RC1 antigen associated with radial glial cells is expressed in ependymal cells and recombined ependymal cells express Sox9, an immature glial marker. The analysis is from uninjured FoxJ1-CreERxR26R mice 6 d after termination of tamoxifen administration. The scale bar indicates 25 mum.
###end p 120
###begin p 121
(5.51 MB TIF)
###end p 121
###begin p 122
Click here for additional data file.
###end p 122
###begin title 123
Molecular Marker Expression by Adult Spinal Cord Ependymal Cells
###end title 123
###begin p 124
###xml 380 396 376 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreERxR26R</italic>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
(A-D) Musashi-1 (Msi1), (E-H) PDGFRalpha and vimentin, all associated with neural stem/progenitor cells, are expressed in recombined ependymal cells. Recombined ependymal cells also express the neural stem cell-associated proteins Sox3 (I-L) and Sox2 (M-O), but not the astrocyte marker GFAP (D) nor the oligodendrocyte progenitor marker Olig2 (P). The analysis is from uninjured FoxJ1-CreERxR26R mice 6 d after termination of tamoxifen administration. The scale bar indicates 25 mum.
###end p 124
###begin p 125
(6.78 MB TIF)
###end p 125
###begin p 126
Click here for additional data file.
###end p 126
###begin title 127
Correlative Light and Electron Microscopy (CLEM) Analysis
###end title 127
###begin p 128
###xml 203 204 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A) Schematic illustration showing the sequence of semithin and ultrathin sections used to study the morphology of cells migrating from the central canal in three dimensions. (B) An example of a beta-gal+ cell identified at the light microscopic level following PAP immunocytochemistry. The labeled cell is shown in an electron micrograph from a neighboring, ultrathin section in (C). The scale bar indicates 2 mum.
###end p 128
###begin p 129
(3.37 MB TIF)
###end p 129
###begin p 130
Click here for additional data file.
###end p 130
###begin title 131
Morphological Features of Ependymal Cells
###end title 131
###begin p 132
(A) An electron micrograph of ependymal cells (e) and tanycytes (t) lining the central canal of the spinal cord. Arrows point to processes extending from tanycytes. The inset shows a light micrograph of a neighboring 2-mum semithin section where the PAP staining is evident. Asterisks mark lipid droplets.
###end p 132
###begin p 133
(B) An ependymal cell with a cilium (c) and multiple villi (v).
###end p 133
###begin p 134
(C) An electron micrograph of a multiciliated tanycyte with a process. Note that the tanycyte has a darker cytoplasm compared to ependymal cells.
###end p 134
###begin p 135
(D) A cross-section of a cilium with microtubules arranged in a 9 + 2 array. Only this type of cilium was found in ependymal cells, tanycytes, and radial ependymal cells.
###end p 135
###begin p 136
(E) The electron dense PAP reaction product signaling for Cre is shown at high magnification.
###end p 136
###begin p 137
(F) An example of an ependymal cell with two cilia. Arrows point to the basal bodies.
###end p 137
###begin p 138
(G) A tight junction (arrow) between an ependymal cell and a tanycyte.
###end p 138
###begin p 139
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(H) An electron micrograph showing a Cre+ radial ependymal cell (r) with a process (arrow) and a lipid droplet (asterisk). The inset shows a light micrograph of the PAP labeling.
###end p 139
###begin p 140
(I) High magnification of the cytoplasm and villi of a radial ependymal cell extending into the lumen of the central canal.
###end p 140
###begin p 141
(J) An electron micrograph of the basal body and cilia of a radial ependymal cell.
###end p 141
###begin p 142
###xml 15 26 15 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxJ1-CreER</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
(A-J) are from FoxJ1-CreER mice.
###end p 142
###begin p 143
###xml 150 162 150 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
(K) Electron micrograph of Cre-immunopositive ependymal cells, radial ependymal cells, and tanycytes at the central canal of the spinal cord from the Nestin-CreER mouse.
###end p 143
###begin p 144
bv: blood vessel; m: mitochondrion; n: nucleus.
###end p 144
###begin p 145
The scale bars indicate 5 mum in (A) and (K), 1 mum in (B), (E), (F), and (J), 2 mum in (C) and (H), 0.1 mum in (D) and (G), and 0.25 mum in (I).
###end p 145
###begin p 146
(7.38 MB TIF)
###end p 146
###begin p 147
Click here for additional data file.
###end p 147
###begin title 148
Exponential Growth of Ependymal Cell-Derived Neurosphere Cells In Vitro
###end title 148
###begin p 149
###xml 126 138 126 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nestin-CreER</italic>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0060182-b066">66</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
The number of cells obtained after sequential clonal passaging, starting with individual recombined primary neurospheres from Nestin-CreER crossed with R26REYFP mice [66]. Each line represents the mean +/- SD from four clones from one animal.
###end p 149
###begin p 150
(124 KB TIF)
###end p 150
###begin p 151
Click here for additional data file.
###end p 151
###begin title 152
Spinal Cord Injury Induces Proliferation of Ependymal Cells
###end title 152
###begin p 153
(A and B) Proliferation and Ki67 expression are induced in ependymal cells close to and in the injury (B), but not in adjacent uninjured segments (A).
###end p 153
###begin p 154
(C) Quantification of the injury-induced proliferative response of ependymal cells at different locations relative to the epicenter of the injury.
###end p 154
###begin p 155
(D-F) Representative image of the quantified area (D), with boxed areas depicting the central canal region (E) and the migrating ependyma-derived cells entering the lesion area (F).
###end p 155
###begin p 156
Scale bars indicate 25 mum in (A), (B), (E), and (F), and 50 mum in (D).
###end p 156
###begin p 157
(3.21 MB TIF)
###end p 157
###begin p 158
Click here for additional data file.
###end p 158
###begin title 159
Migration of Ependymal Cell Progeny to Lateral Spinal Cord Lesions
###end title 159
###begin p 160
(A-C) Distribution of beta-gal-immunoreactive ependymal cells and their progeny 2 wk after a laminectomy only (sham [A]) and a right (B) or a left (C) lateral funiculus incision. GFAP immunoreactivity demarcates the injury site (indicated by hatched lines).
###end p 160
###begin p 161
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Four weeks after a lateral injury, ependymal cells give rise to Sox9+ (D), GFAP+ (E), and Olig2+ (F) cells, as after a dorsal funiculus lesion.
###end p 161
###begin p 162
Scale bars indicate 200 mum in (A-C) and 20 mum in (D-F).
###end p 162
###begin p 163
(2.22 MB TIF)
###end p 163
###begin p 164
Click here for additional data file.
###end p 164
###begin title 165
Relationship between Ependymal Cells, Their Progeny, and CXCR4 Immunoreactivity
###end title 165
###begin p 166
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
(A-F) Most ependymal cells (identified by beta-gal and vimentin in a FoxJ1-CreERxR26R mouse) do not display detectable CXCR4-immunoreactivty (yellow arrowheads), although some ependymal cell processes appear CXCR4-immunoreactive (white arrowheads).
###end p 166
###begin p 167
(G-I) Two weeks after a dorsal funiculus lesion, many cells in the forming scar tissue are CXCR4 immunoreactive, but the beta-gal-expressing ependyma-derived cells appear negative for CXCR4.
###end p 167
###begin p 168
Scale bars indicate 25 mum in (A-F) and 50 mum in (G-I).
###end p 168
###begin p 169
(3.27 MB TIF)
###end p 169
###begin p 170
Click here for additional data file.
###end p 170
###begin title 171
Central Canal Ependymal Cells Are Not Depleted after Injury and Maintain Their Phenotype over 8 Mo
###end title 171
###begin p 172
(A and B) A sagittal section showing Sox9 and vimentin expression in recombined ependymal cells of the central canal in an uninjured segment 8 mo after spinal cord injury.
###end p 172
###begin p 173
###xml 86 87 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 259 260 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 268 269 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(C-E) In the injured segment of the same animal, ependyma-derived recombined (beta-gal+) cells occupying the scar tissue ([C] and higher magnification in [D]) as well as ependymal cells at the central canal ([C] and higher magnification in [E]) are still Sox9+ and Vim+ 8 mo after injury.
###end p 173
###begin p 174
Scale bars indicate 25 mum in (A) and (D) and 100 mum in (C) and (E).
###end p 174
###begin p 175
(3.87 MB TIF)
###end p 175
###begin p 176
Click here for additional data file.
###end p 176
###begin title 177
Identification of an Ependyma-Derived Cell at the Ultrastructural Level
###end title 177
###begin p 178
(A and B) The nuclei of an ependyma-derived beta-gal-immunoreactive cell and surrounding cells were labeled with DAPI. The beta-gal-immunoreactive cell was identified in the electron microscope by the position of the nucleus in a 3D reconstruction of serial 120-nm-thick sections of the whole area.
###end p 178
###begin p 179
(C) The beta-gal-immunoreactive cell is indicated by an asterisk and surrounding cells are numbered. BV: blood vessel.
###end p 179
###begin p 180
Scale bars indicate 10 mum.
###end p 180
###begin p 181
(907 KB TIF)
###end p 181
###begin p 182
Click here for additional data file.
###end p 182
###begin title 183
Morphological Characteristics of Ependymal Cells
###end title 183
###begin p 184
###xml 163 171 163 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">Figure 1</xref>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0060182-g001">Figure 1</xref>
Details for the studied cells lining the central canal of the spinal cord by immunoelectron microscopy, which underlie classification into the cell types shown in Figure 1. Each cell shown in the table was traced in complete series of ultrathin sections. Color coding corresponds to the Venn diagram in Figure 1. Ependymal cells are cyan, tanycytes are orange, and radial ependymal cells are purple. Green represents an intermediate population of cells with a dark cytoplasm, without any process. Black represents a second intermediate population with a light cytoplasm, multiple cilia, and with a process. Red represents a population of cells with an irregular nucleus, light cytoplasm, a process, and only one cilium.
###end p 184
###begin p 185
(323 KB TIF)
###end p 185
###begin p 186
Click here for additional data file.
###end p 186
###begin p 187
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2</sup>
We are indebted to K. Fernandes, O. Hermanson, U. Lendahl for valuable discussions, L. Ostrowski for the FoxJ1 promoter construct, Daniel Metzger and Pierre Chambon for the Cre-ERT2 cDNA, and Karin Hamrin and Marcelo Toro for help with flow cytometry.
###end p 187
###begin title 188
Abbreviations
###end title 188
###begin p 189
beta-galactosidase
###end p 189
###begin p 190
5-bromo-2-deoxyuridine
###end p 190
###begin p 191
tamoxifen-dependent Cre recombinase
###end p 191
###begin p 192
chondroitin sulphate proteoglycans
###end p 192
###begin p 193
green fluorescent protein
###end p 193
###begin p 194
glial fibrillary acidic protein
###end p 194
###begin p 195
myelin basic protein
###end p 195
###begin p 196
standard deviation
###end p 196
###begin title 197
References
###end title 197
###begin article-title 198
Therapeutic interventions after spinal cord injury
###end article-title 198
###begin article-title 199
Functional considerations of stem cell transplantation therapy for spinal cord repair
###end article-title 199
###begin article-title 200
Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis
###end article-title 200
###begin article-title 201
FGF-2 is sufficient to isolate progenitors found in the adult mammalian spinal cord
###end article-title 201
###begin article-title 202
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome
###end article-title 202
###begin article-title 203
Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord
###end article-title 203
###begin article-title 204
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord
###end article-title 204
###begin article-title 205
Identification of a neural stem cell in the adult mammalian central nervous system
###end article-title 205
###begin article-title 206
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord
###end article-title 206
###begin article-title 207
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
The winged helix transcription factor HFH-4 is expressed during choroid plexus epithelial development in the mouse embryo
###end article-title 207
###begin article-title 208
Forkhead transcription factor HFH-4 expression is temporally related to ciliogenesis
###end article-title 208
###begin article-title 209
Primary structure of hepatocyte nuclear factor/forkhead homologue 4 and characterization of gene expression in the developing respiratory and reproductive epithelium
###end article-title 209
###begin article-title 210
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter
###end article-title 210
###begin article-title 211
Regeneration of a germinal layer in the adult mammalian brain
###end article-title 211
###begin article-title 212
CNS stem cells express a new class of intermediate filament protein
###end article-title 212
###begin article-title 213
Identification of major cell classes in the developing mammalian nervous system
###end article-title 213
###begin article-title 214
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
###end article-title 214
###begin article-title 215
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
Nestin-EGFP transgenic mice: visualization of the self-renewal and multipotency of CNS stem cells
###end article-title 215
###begin article-title 216
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain
###end article-title 216
###begin article-title 217
Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury
###end article-title 217
###begin article-title 218
Genetic visualization of neurogenesis
###end article-title 218
###begin article-title 219
Generalized lacZ expression with the Rosa26 Cre reporter strain
###end article-title 219
###begin article-title 220
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision
###end article-title 220
###begin article-title 221
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
###end article-title 221
###begin article-title 222
###xml 68 72 <span type="species:ncbi:10116">rats</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 112 119 <span type="species:ncbi:9606">patient</span>
Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient
###end article-title 222
###begin article-title 223
Neural stem cells and neurospheres-re-evaluating the relationship
###end article-title 223
###begin article-title 224
Stem and progenitor cells: the premature desertion of rigorous definitions
###end article-title 224
###begin article-title 225
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation
###end article-title 225
###begin article-title 226
Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury
###end article-title 226
###begin article-title 227
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway
###end article-title 227
###begin article-title 228
Persistent production of neurons from adult brain stem cells during recovery after stroke
###end article-title 228
###begin article-title 229
Regeneration of adult axons in white matter tracts of the central nervous system
###end article-title 229
###begin article-title 230
Regeneration beyond the glial scar
###end article-title 230
###begin article-title 231
The role of extracellular matrix in CNS regeneration
###end article-title 231
###begin article-title 232
The extracellular matrix in axon regeneration
###end article-title 232
###begin article-title 233
Astrocyte-associated fibronectin is critical for axonal regeneration in adult white matter
###end article-title 233
###begin article-title 234
Spinal axons in CNS scar tissue are closely related to laminin-immunoreactive astrocytes
###end article-title 234
###begin article-title 235
Growth of ascending spinal axons in CNS scar tissue
###end article-title 235
###begin article-title 236
From stem cell to progenitor and back again
###end article-title 236
###begin article-title 237
EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells
###end article-title 237
###begin article-title 238
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis
###end article-title 238
###begin article-title 239
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord
###end article-title 239
###begin article-title 240
Fate of endogenous stem/progenitor cells following spinal cord injury
###end article-title 240
###begin article-title 241
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Transcription factor expression and Notch-dependent regulation of neural progenitors in the adult rat spinal cord
###end article-title 241
###begin article-title 242
Cell proliferation and replacement following contusive spinal cord injury
###end article-title 242
###begin article-title 243
Mixed primary culture and clonal analysis provide evidence that NG2 proteoglycan-expressing cells after spinal cord injury are glial progenitors
###end article-title 243
###begin article-title 244
Overcoming inhibition in the damaged spinal cord
###end article-title 244
###begin article-title 245
Nogo and axon regeneration
###end article-title 245
###begin article-title 246
Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury
###end article-title 246
###begin article-title 247
A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord
###end article-title 247
###begin article-title 248
Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates
###end article-title 248
###begin article-title 249
Strategies to promote neural repair and regeneration after spinal cord injury
###end article-title 249
###begin article-title 250
Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion
###end article-title 250
###begin article-title 251
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Glial cell loss, proliferation and replacement in the contused murine spinal cord
###end article-title 251
###begin article-title 252
Demyelination in spinal cord injury
###end article-title 252
###begin article-title 253
Suppression of remyelination in the CNS by X-irradiation
###end article-title 253
###begin article-title 254
Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord
###end article-title 254
###begin article-title 255
Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury
###end article-title 255
###begin article-title 256
Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors
###end article-title 256
###begin article-title 257
###xml 63 68 <span type="species:ncbi:9606">human</span>
An evolutionarily conserved region in the second intron of the human nestin gene directs gene expression to CNS progenitor cells and to early neural crest cells
###end article-title 257
###begin article-title 258
Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases
###end article-title 258
###begin article-title 259
###xml 59 64 <span type="species:ncbi:9606">human</span>
Expression of the class VI intermediate filament nestin in human central nervous system tumors
###end article-title 259
###begin article-title 260
Adult rodent neurogenic regions: the ventricular subependyma contains neural stem cells, but the dentate gyrus contains restricted progenitors
###end article-title 260
###begin article-title 261
Doublet discrimination in DNA cell-cycle analysis
###end article-title 261
###begin article-title 262
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
###end article-title 262
###begin p 263
currencya Current address: Department of Brain and Cognitive Sciences, Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
###end p 263
###begin p 264
currencyb Current address: Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, United Kingdom
###end p 264
###begin p 265
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. KM, FBH, MC, and JF conceived and designed the experiments. KM, FBH, MC, EE, NT, OS, and JF performed the experiments and analyzed the data. KM, FBH, MC, and JF wrote the paper.
###end p 265
###begin p 266
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Foundation for Strategic Research, the Karolinska Institute, Tobias Stiftelsen, Wallenbergs Stiftelsen, and the European Commission Framework VI Programme, EuroStemCell. FBH. was supported by postdoctoral fellowships from Canadian Institutes of Health Research (CIHR) and Christopher and Dana Reeve Foundation, and MC and EE were supported by postdoctoral fellowship from the Swedish Brain Foundation.
###end p 266
###begin p 267
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 267

